THE EFFECT OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE HYDROCHLORIDE ON MURINE NEOPLASMS.
D000818:Animals; D000900:Anti-Bacterial Agents; D000906:Antibodies; D000970:Antineoplastic Agents; D001773:Blood Cells; D002286:Carcinoma, Ehrlich Tumor; D003348:Cortisone; D003561:Cytarabine; D003596:Cytosine; D007939:Leukemia L1210; D007942:Leukemia, Experimental; D008223:Lymphoma; D015122:Mercaptopurine; D008727:Methotrexate; D051379:Mice; D009369:Neoplasms; D009374:Neoplasms, Experimental; D010600:Pharmacology; D012106:Research; D012510:Sarcoma 180
D000900:Anti-Bacterial Agents; D000906:Antibodies; D000970:Antineoplastic Agents; D003561:Cytarabine; D003596:Cytosine; D015122:Mercaptopurine; D003348:Cortisone; D008727:Methotrexate
ANTIBIOTICS; ANTIBODIES; ANTINEOPLASTIC AGENTS; BLOOD CELLS; CARCINOMA, EHRLICH TUMOR; CORTISONE; CYTOSINE; EXPERIMENTAL LAB STUDY; LEUKEMIA L1210; LEUKEMIA, EXPERIMENTAL; LYMPHOMA; MERCAPTOPURINE; METHOTREXATE; MICE; NEOPLASMS, EXPERIMENTAL; PHARMACOLOGY; SARCOMA 180, CROCKER